Asia-Pacific cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.2% during the forecast period. The significant prevalence of cancer and increasing launches of new monoclonal antibodies are some pivotal factors accelerating market growth. As per the World Health Organization (WHO), the number of new cancer incidences in China was nearly 4.3 million in 2018. Additionally, the number of new cancer incidences in India was nearly 1.1 million in 2018. Improving healthcare infrastructure and increasing awareness has led to the demand for novel cancer therapies in the region. This, in turn, is driving the demand for monoclonal antibodies that acts as a targeted therapy to better recognize and destroy cancer cells. Some monoclonal antibodies drugs launched in the region include Avastin biosimilar, Tecentriq, XGEVA (denosumab), and others.
Get Free Sample link @ https://www.omrglobal.com/request-sample/asia-pacific-cancer-monoclonal-antibodies-market
Asia-Pacific cancer monoclonal antibodies market is segmented based on type and application. Based on type, the market is classified into naked, conjugated, and others. Based on the application, the market is classified into breast cancer, liver cancer, blood cancer, brain cancer, colorectal cancer, and others. Monoclonal antibodies find significant application in breast cancer coupled with the rising incidences of breast cancer in the region. As per the WHO, in India, breast cancer accounted for 14.0% or 162,468, while in China, it accounted for 8.6% or 367,900 of all cancer types in 2018. Kadcyla, (also referred to as TDM-1) targets the HER2 protein like Herceptin. These therapies act against the HER2 protein as this protein is found in massive amounts on certain kinds of breast cancer cells. The therapy is utilized for the treatment of HER2-positive breast cancer. Most often monoclonal antibodies are combined with additional cancer-fighting drugs, including chemotherapy.
A full report of Asia-Pacific Cancer Monoclonal Antibodies Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-cancer-monoclonal-antibodies-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Asia-Pacific Cancer Monoclonal Antibodies Market by Type
- Naked
- Conjugated
- Others (Bispecific)
Asia-Pacific Cancer Monoclonal Antibodies Market by Application
- Breast Cancer
- Liver Cancer
- Blood Cancer
- Brain Cancer
- Colorectal Cancer
- Others
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Amgen Inc.
- Anhui Anke Biotechnology (Group) Co., Ltd.
- Biocon Ltd.
- Chugai Pharmaceutical Co., Ltd.
- Daiichi Sankyo Company, Ltd.
- Reddy’s Laboratories, Inc.
- Genor BioPharma Co., Ltd.
- Lupin Ltd.
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
The Report Covers
- Comprehensive research methodology of the Asia-Pacific cancer monoclonal antibodies market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific cancer monoclonal antibodies market.
- Insights about market determinants which are stimulating the Asia-Pacific cancer monoclonal antibodies market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-cancer-monoclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
